Cell pathology in bipolar disorder

Objectives: The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to demonstrate that impairments of cell morphology and resilience may underlie the neurobiology of BPD. Methods: Reports of alterations in n...

Full description

Saved in:
Bibliographic Details
Published in:Bipolar disorders Vol. 4; no. 2; pp. 105 - 116
Main Author: Rajkowska, Grazyna
Format: Journal Article
Language:English
Published: Oxford UK Munksgaard International Publishers 01.04.2002
Subjects:
ISSN:1398-5647, 1399-5618
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Objectives: The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to demonstrate that impairments of cell morphology and resilience may underlie the neurobiology of BPD. Methods: Reports of alterations in number, density and size of neurons and glial cells in BPD are reviewed. Owing to the low number of postmortem studies on cellular pathology in BPD, s of recent symposia are also discussed. Results and Conclusions: In BPD, significant reductions in the volume of several brain regions, as well as region‐ and layer‐specific reductions in the number, density and/or size of neurons and glial cells have been demonstrated. Moreover, the results of recent clinical and preclinical studies investigating the molecular and cellular targets of mood stabilizing and antidepressant medications provide intriguing possibilities that impairments in neuroplasticity and cellular resilience may underlie the neurobiology of BPD. Future studies will likely examine the role of both genetic and environmental factors in the pathogenesis and cellular changes in BPD.
AbstractList The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to demonstrate that impairments of cell morphology and resilience may underlie the neurobiology of BPD.OBJECTIVESThe objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to demonstrate that impairments of cell morphology and resilience may underlie the neurobiology of BPD.Reports of alterations in number, density and size of neurons and glial cells in BPD are reviewed. Owing to the low number of postmortem studies on cellular pathology in BPD, abstracts of recent symposia are also discussed.METHODSReports of alterations in number, density and size of neurons and glial cells in BPD are reviewed. Owing to the low number of postmortem studies on cellular pathology in BPD, abstracts of recent symposia are also discussed.In BPD. significant reductions in the volume of several brain regions, as well as region- and layer-specific reductions in the number, density and/or size of neurons and glial cells have been demonstrated. Moreover, the results of recent clinical and preclinical studies investigating the molecular and cellular targets of mood stabilizing and antidepressant medications provide intriguing possibilities that impairments in neuroplasticity and cellular resilience may underlie the neurobiology of BPD. Future studies will likely examine the role of both genetic and environmental factors in the pathogenesis and cellular changes in BPD.RESULTS AND CONCLUSIONSIn BPD. significant reductions in the volume of several brain regions, as well as region- and layer-specific reductions in the number, density and/or size of neurons and glial cells have been demonstrated. Moreover, the results of recent clinical and preclinical studies investigating the molecular and cellular targets of mood stabilizing and antidepressant medications provide intriguing possibilities that impairments in neuroplasticity and cellular resilience may underlie the neurobiology of BPD. Future studies will likely examine the role of both genetic and environmental factors in the pathogenesis and cellular changes in BPD.
Objectives: The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to demonstrate that impairments of cell morphology and resilience may underlie the neurobiology of BPD. Methods: Reports of alterations in number, density and size of neurons and glial cells in BPD are reviewed. Owing to the low number of postmortem studies on cellular pathology in BPD, abstracts of recent symposia are also discussed. Results and Conclusions: In BPD, significant reductions in the volume of several brain regions, as well as region‐ and layer‐specific reductions in the number, density and/or size of neurons and glial cells have been demonstrated. Moreover, the results of recent clinical and preclinical studies investigating the molecular and cellular targets of mood stabilizing and antidepressant medications provide intriguing possibilities that impairments in neuroplasticity and cellular resilience may underlie the neurobiology of BPD. Future studies will likely examine the role of both genetic and environmental factors in the pathogenesis and cellular changes in BPD.
Objectives: The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to demonstrate that impairments of cell morphology and resilience may underlie the neurobiology of BPD. Methods: Reports of alterations in number, density and size of neurons and glial cells in BPD are reviewed. Owing to the low number of postmortem studies on cellular pathology in BPD, abstracts of recent symposia are also discussed. Results and Conclusions: In BPD, significant reductions in the volume of several brain regions, as well as region- and layer-specific reductions in the number, density and/or size of neurons and glial cells have been demonstrated. Moreover, the results of recent clinical and preclinical studies investigating the molecular and cellular targets of mood stabilizing and antidepressant medications provide intriguing possibilities that impairments in neuroplasticity and cellular resilience may underlie the neurobiology of BPD. Future studies will likely examine the role of both genetic and environmental factors in the pathogenesis and cellular changes in BPD.
The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to demonstrate that impairments of cell morphology and resilience may underlie the neurobiology of BPD. Reports of alterations in number, density and size of neurons and glial cells in BPD are reviewed. Owing to the low number of postmortem studies on cellular pathology in BPD, abstracts of recent symposia are also discussed. In BPD. significant reductions in the volume of several brain regions, as well as region- and layer-specific reductions in the number, density and/or size of neurons and glial cells have been demonstrated. Moreover, the results of recent clinical and preclinical studies investigating the molecular and cellular targets of mood stabilizing and antidepressant medications provide intriguing possibilities that impairments in neuroplasticity and cellular resilience may underlie the neurobiology of BPD. Future studies will likely examine the role of both genetic and environmental factors in the pathogenesis and cellular changes in BPD.
Objectives: The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to demonstrate that impairments of cell morphology and resilience may underlie the neurobiology of BPD. Methods: Reports of alterations in number, density and size of neurons and glial cells in BPD are reviewed. Owing to the low number of postmortem studies on cellular pathology in BPD, s of recent symposia are also discussed. Results and Conclusions: In BPD, significant reductions in the volume of several brain regions, as well as region‐ and layer‐specific reductions in the number, density and/or size of neurons and glial cells have been demonstrated. Moreover, the results of recent clinical and preclinical studies investigating the molecular and cellular targets of mood stabilizing and antidepressant medications provide intriguing possibilities that impairments in neuroplasticity and cellular resilience may underlie the neurobiology of BPD. Future studies will likely examine the role of both genetic and environmental factors in the pathogenesis and cellular changes in BPD.
Author Rajkowska, Grazyna
Author_xml – sequence: 1
  givenname: Grazyna
  surname: Rajkowska
  fullname: Rajkowska, Grazyna
  organization: Laboratory of Quantitative Neuroanatomy, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12071508$$D View this record in MEDLINE/PubMed
BookMark eNqNkE9P4zAQxS0E4t_yFVC0h70ljOM4ti8rLWULSBUrrXYFt5ETO-CSxsVOte23J6WlBy7saZ40b37Pfidkv_OdJSShkFFgxcU0o0yplJdUZjlAngGlhcqWe-R4t9h_03LQhTgiJzFOAWiZAz8kRzQHQTnIY_J1ZNs2mev-ybf-cZW4Lqnc3Lc6JMZFH4wNX8hBo9toz7bzlPwd__wzukknv65vRz8mac2BqjRvRKWk0iqXUkvgjRlCTGEbqAXjpdUVq1RTFkw1jTZW5UC1qqguwQgtjGGn5NuGOw_-ZWFjjzMX6-F5urN-EVFQyQoB8KmRCi4LIfhgPN8aF9XMGpwHN9Nhhe_fHwzfN4Y6-BiDbbB2ve6d7_qgXYsUcN03TnFdK65rxXXf-NY3LgeA_ADYZXx-us3-51q7-u87vLy6pb8HOQDSDcDF3i53AB2esRRMcLy_u0aVX07Gk_EDCvYK8hGk0g
CitedBy_id crossref_primary_10_1038_s41380_023_02313_7
crossref_primary_10_1111_j_1399_5618_2007_00361_x
crossref_primary_10_1016_j_pnpbp_2017_04_033
crossref_primary_10_1016_S1566_2772_02_00044_0
crossref_primary_10_1016_j_neulet_2008_07_081
crossref_primary_10_1017_S1092852900020095
crossref_primary_10_1111_j_1399_5618_2012_01033_x
crossref_primary_10_1111_j_1748_720X_2010_00533_x
crossref_primary_10_1016_j_biopsych_2012_06_010
crossref_primary_10_1089_104454603322724931
crossref_primary_10_3390_cells8111424
crossref_primary_10_1177_0269881119895534
crossref_primary_10_1016_j_biopsych_2006_03_022
crossref_primary_10_1034_j_1399_5618_2002_00001_x
crossref_primary_10_1038_tp_2012_34
crossref_primary_10_1111_j_1399_5618_2011_00946_x
crossref_primary_10_1016_j_expneurol_2011_03_008
crossref_primary_10_1016_S0006_3223_03_00171_9
crossref_primary_10_1097_CHI_0b013e31817eecd9
crossref_primary_10_1038_sj_npp_1300740
crossref_primary_10_1038_sj_npp_1301312
crossref_primary_10_1111_j_1399_5618_2008_00435_x
crossref_primary_10_1258_ebm_2009_009225
crossref_primary_10_1016_j_biopsych_2006_07_035
crossref_primary_10_1021_cn500038f
crossref_primary_10_1097_YCO_0b013e32832a1353
crossref_primary_10_1017_S146114571000146X
crossref_primary_10_1016_j_neubiorev_2009_10_012
crossref_primary_10_1016_j_jad_2017_05_025
crossref_primary_10_1111_bdi_12262
crossref_primary_10_1111_j_1528_1167_2005_463004_x
crossref_primary_10_1038_sj_npp_1300731
crossref_primary_10_1007_s11011_013_9473_4
crossref_primary_10_1080_14737175_2017_1240615
crossref_primary_10_2174_0929867330666230523155728
crossref_primary_10_1383_psyt_2006_5_5_180
crossref_primary_10_1016_j_paid_2009_04_017
crossref_primary_10_1016_j_ddmec_2004_11_020
crossref_primary_10_1016_S0006_3223_03_00117_3
crossref_primary_10_1007_s11064_007_9526_3
crossref_primary_10_1016_j_nbd_2009_11_010
crossref_primary_10_1177_0269881114529379
crossref_primary_10_1046_j_1471_4159_2003_02276_x
crossref_primary_10_1016_j_neuroimage_2007_05_062
crossref_primary_10_2353_ajpath_2010_081068
crossref_primary_10_3389_fpsyt_2020_00071
crossref_primary_10_1016_j_biopsych_2006_04_026
crossref_primary_10_1016_j_jad_2010_12_018
crossref_primary_10_1038_tp_2012_55
crossref_primary_10_1016_j_pnpbp_2012_11_015
crossref_primary_10_1111_j_1399_5618_2009_00697_x
crossref_primary_10_1038_sj_npp_1300565
crossref_primary_10_1007_s12017_010_8140_8
crossref_primary_10_1002_jnr_20875
crossref_primary_10_1139_jpn_0720
crossref_primary_10_2217_fnl_2016_0003
crossref_primary_10_1038_sj_npp_1301405
crossref_primary_10_1111_j_1399_5618_2009_00666_x
crossref_primary_10_3389_fncel_2015_00468
crossref_primary_10_1007_s11064_008_9817_3
crossref_primary_10_1002_jms_5143
crossref_primary_10_1016_j_cnr_2004_09_005
crossref_primary_10_1038_mp_2009_47
crossref_primary_10_1016_j_nurx_2005_12_009
crossref_primary_10_1007_s11655_011_0666_6
crossref_primary_10_1176_foc_9_4_foc526
crossref_primary_10_1016_j_neubiorev_2014_02_004
crossref_primary_10_1007_s11920_012_0319_2
crossref_primary_10_1155_2011_174689
crossref_primary_10_1139_jpn_0609
crossref_primary_10_1186_s40345_017_0104_6
crossref_primary_10_1016_j_jad_2015_04_016
crossref_primary_10_1016_j_ygeno_2004_08_015
crossref_primary_10_1016_j_bbr_2012_07_026
crossref_primary_10_1038_sj_mp_4001648
crossref_primary_10_1016_j_pnpbp_2008_01_006
crossref_primary_10_1038_sj_mp_4001888
crossref_primary_10_1111_bdi_12720
crossref_primary_10_1038_sj_mp_4001887
crossref_primary_10_1111_j_1399_5618_2009_00752_x
crossref_primary_10_1111_j_1751_7893_2008_00071_x
crossref_primary_10_1038_sj_mp_4001521
crossref_primary_10_1111_j_1440_1819_2010_02178_x
crossref_primary_10_1007_s00210_023_02437_1
crossref_primary_10_1196_annals_1300_017
crossref_primary_10_1016_S0006_3223_02_01911_X
crossref_primary_10_1111_bdi_12856
crossref_primary_10_1016_j_ejphar_2006_03_076
crossref_primary_10_1016_j_pscychresns_2009_09_004
crossref_primary_10_1038_mp_2008_99
crossref_primary_10_1111_j_1399_5618_2009_00714_x
crossref_primary_10_1016_j_biopsych_2005_10_021
crossref_primary_10_1016_j_ceca_2011_04_006
crossref_primary_10_1038_npp_2009_151
crossref_primary_10_1016_j_biopsych_2003_12_014
crossref_primary_10_1093_ijnp_pyw051
crossref_primary_10_1093_brain_awq236
crossref_primary_10_1016_j_neuroscience_2010_03_029
crossref_primary_10_1017_S1461145708009310
crossref_primary_10_1038_sj_tpj_6500266
crossref_primary_10_3109_15622975_2010_507784
crossref_primary_10_1111_j_1601_5215_2008_00291_x
crossref_primary_10_1111_j_1399_5618_2003_00095_x
crossref_primary_10_1111_j_1399_5618_2006_00302_x
crossref_primary_10_3390_brainsci11020228
crossref_primary_10_1186_s12916_024_03725_0
crossref_primary_10_1016_j_euroneuro_2004_09_002
crossref_primary_10_1016_j_biopsych_2006_08_048
crossref_primary_10_1016_j_jad_2004_12_008
crossref_primary_10_1017_S146114570900025X
crossref_primary_10_1016_j_neulet_2007_05_016
crossref_primary_10_1038_s41398_024_02811_4
crossref_primary_10_1111_j_1471_4159_2007_04648_x
crossref_primary_10_1177_1073858403252773
crossref_primary_10_1016_j_biopsych_2003_10_017
crossref_primary_10_1016_j_neulet_2006_10_031
crossref_primary_10_1038_s41380_022_01909_9
crossref_primary_10_1017_neu_2016_56
crossref_primary_10_1007_s12035_016_9933_z
crossref_primary_10_1038_npp_2012_172
crossref_primary_10_1038_tp_2016_284
crossref_primary_10_1097_chi_0b013e31802f5f2c
crossref_primary_10_1172_JCI37703
crossref_primary_10_1007_s40263_013_0039_0
crossref_primary_10_1016_j_phrs_2025_107691
crossref_primary_10_1016_j_brainres_2007_01_147
crossref_primary_10_1038_sj_npp_1301575
crossref_primary_10_1503_jpn_100048
crossref_primary_10_1007_s12031_008_9122_2
crossref_primary_10_1038_npp_2010_74
crossref_primary_10_1097_YPG_0b013e328010f28c
crossref_primary_10_1016_j_jad_2017_05_008
Cites_doi 10.1016/0022-510X(85)90141-8
10.1016/S0006-3223(99)00165-1
10.1016/S0006-8993(98)01362-6
10.1176/ajp.151.5.687
10.1016/S0006-3223(99)00177-8
10.1016/S0165-0327(98)00168-2
10.1074/jbc.275.11.7583
10.1176/ajp.153.2.151
10.1016/S0006-3223(98)00084-5
10.1192/bjp.169.4.509
10.1016/S0079-6123(00)26026-3
10.1523/JNEUROSCI.10-09-02897.1990
10.1523/JNEUROSCI.16-03-00877.1996
10.1016/0165-0327(94)00089-R
10.1016/S0006-3223(01)01083-6
10.1016/0165-0327(82)90014-3
10.1002/(sici)1096-9861(19960729)371:3<362::aid-cne2>3.0.co;2-0
10.1097/00001756-199502000-00015
10.1016/S0006-3223(99)00235-8
10.1038/368059a0
10.1016/S0006-3223(96)00373-3
10.1126/science.7907431
10.1111/j.1365-2826.1994.tb00634.x
10.1038/386824a0
10.1016/S0079-6123(08)64586-0
10.1176/jnp.3.1.18
10.1016/S0306-4530(97)00021-8
10.1001/archpsyc.1991.01810290094018
10.1001/archpsyc.1996.01830020055007
10.1523/JNEUROSCI.15-11-07539.1995
10.1016/S0006-3223(98)00138-3
10.1073/pnas.98.4.1964
10.1146/annurev.pa.33.040193.001121
10.1016/0165-3806(92)90103-4
10.1176/ajp.156.12.1895
10.1176/jnp.1.2.128
10.1001/archpsyc.55.3.215
10.1001/archpsyc.1995.03950220015005
10.1176/ajp.156.12.1986
10.1016/S0006-3223(99)00183-3
10.1016/S0006-3223(01)01080-0
10.1001/archpsyc.58.6.545
10.1007/BF00185889
10.1016/0014-4886(91)90041-A
10.1152/physrev.1998.78.1.99
10.1007/s002130051062
10.1001/archpsyc.1995.03950210041009
10.1002/syn.890140303
10.1016/S0920-9964(99)00112-7
10.1016/0304-3940(91)90583-F
10.1046/j.1471-4159.1999.0731121.x
10.1016/S0006-3223(01)01084-8
10.1016/0896-6273(90)90089-X
10.1016/S0006-3223(00)00552-7
10.1016/0165-0327(86)90036-4
10.1016/S0006-3223(00)00252-3
10.1016/S0006-3223(99)00266-8
10.1001/archpsyc.55.7.663
10.1016/S0006-3223(00)00962-8
10.1006/exnr.1997.6719
10.1016/S0006-3223(96)00006-6
10.1176/ajp.154.8.1148
10.1001/archpsyc.1989.01810030049007
10.1159/000126839
10.1002/(sici)1096-9861(19980808)395:3<310::aid-cne4>3.0.co;2-5
10.1126/science.277.5332.1684
10.1016/S0920-9964(99)00063-8
10.1016/S0920-9964(00)90551-6
10.1002/hipo.450020410
10.1176/ajp.152.6.915
10.1111/j.1460-9568.1991.tb00854.x
10.1038/sj.mp.4000494
10.1098/rstb.1999.0471
10.1001/archpsyc.1997.01830190015002
10.1016/0006-3223(90)90416-Y
10.1523/JNEUROSCI.05-03-00776.1985
10.1097/00001756-199806220-00021
10.1038/sj.mp.4000811
10.1001/archpsyc.1990.01810230070011
10.1016/0006-3223(94)91201-7
10.1073/pnas.95.22.13290
10.1196/annals.1316.075
10.1159/000212546
10.1016/0301-0082(95)00014-M
10.1016/S0006-3223(00)00999-9
10.1017/S003329170003347X
10.1046/j.1471-4159.2000.0751729.x
10.1001/archpsyc.1995.03950210029008
10.1097/00001756-199904060-00040
10.1159/000126778
10.1074/jbc.274.10.6039
10.1016/S0006-3223(99)00041-4
10.1097/00004583-199506000-00014
10.1176/ajp.152.9.1372
10.1111/j.1749-6632.1999.tb09292.x
10.1016/S0006-3223(00)00971-9
10.1046/j.1471-4159.1999.720879.x
10.1038/sj.mp.4000696
ContentType Journal Article
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
DOI 10.1034/j.1399-5618.2002.01149.x
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
Neurosciences Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1399-5618
EndPage 116
ExternalDocumentID 12071508
10_1034_j_1399_5618_2002_01149_x
BDI1R149
ark_67375_WNG_92BLFLFX_7
Genre reviewArticle
Research Support, U.S. Gov't, P.H.S
Review
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: MH 55872
– fundername: NIMH NIH HHS
  grantid: MH 45488
– fundername: NIMH NIH HHS
  grantid: MH 44866
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OC
23N
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAKAS
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAHHS
ACCFJ
ADZOD
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
WRC
AAYXX
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
ID FETCH-LOGICAL-c5019-2f7b989a9288a805fd207d4ef0c7356eab3b9f6439ffade9201a9b1a60d7a7dd3
IEDL.DBID DRFUL
ISICitedReferencesCount 156
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000175195800004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1398-5647
IngestDate Fri Jul 11 07:19:31 EDT 2025
Sun Nov 09 13:33:47 EST 2025
Wed Feb 19 01:32:55 EST 2025
Tue Nov 18 22:43:16 EST 2025
Sat Nov 29 03:32:53 EST 2025
Wed Jan 22 16:30:04 EST 2025
Sun Sep 21 06:18:20 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5019-2f7b989a9288a805fd207d4ef0c7356eab3b9f6439ffade9201a9b1a60d7a7dd3
Notes ArticleID:BDI1R149
ark:/67375/WNG-92BLFLFX-7
istex:216338411E9935F7D6FDBDC7E295858DDCA57018
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 12071508
PQID 17584775
PQPubID 23462
PageCount 12
ParticipantIDs proquest_miscellaneous_71834700
proquest_miscellaneous_17584775
pubmed_primary_12071508
crossref_citationtrail_10_1034_j_1399_5618_2002_01149_x
crossref_primary_10_1034_j_1399_5618_2002_01149_x
wiley_primary_10_1034_j_1399_5618_2002_01149_x_BDI1R149
istex_primary_ark_67375_WNG_92BLFLFX_7
PublicationCentury 2000
PublicationDate April 2002
PublicationDateYYYYMMDD 2002-04-01
PublicationDate_xml – month: 04
  year: 2002
  text: April 2002
PublicationDecade 2000
PublicationPlace Oxford UK
PublicationPlace_xml – name: Oxford UK
– name: Denmark
PublicationTitle Bipolar disorders
PublicationTitleAlternate Bipolar Disord
PublicationYear 2002
Publisher Munksgaard International Publishers
Publisher_xml – name: Munksgaard International Publishers
References Selemon LD, Goldman-Rakic PS. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 1985; 5: 776-794.
Hauser P, Altshuler LL, Berrettini W, Dauphinais ID, Gelernter J, Post RM. Temporal lobe measurement in primary affective disorder by magnetic resonance imaging. J Neuropsychiatry Clin Neurosci 1989; 1: 128-134.
Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995; 52: 805-818.
Blumberg HP, Stern E, Martinez D et al. Increased anterior cingulate and caudate activity in bipolar mania [In Process Citation]. Biol Psychiatry 2000; 48: 1045-1052.
Rajkowska G. Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits? Prog Brain Res 2000; 126: 397-412.
Elkis H, Friedman L, Wise A, Meltzer HY. Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Arch Gen Psychiatry 1995; 52: 735-746.
Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 1997; 154: 1148-1150.
Soares J, Mann J. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997; 41: 86-106.
Hoogendijk JE, Fliers E, Swaab DF, Verwer RW. Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia. J Neurol Sci 1985; 69: 291-299.
Watanabe Y, Gould E, Cameron HA, Daniels DC, McEwen BS. Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 1992; 2: 431-435.
Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1155-1163.
Lim KO, Rosenbloom MJ, Faustman WO, Sullivan EV, Pfefferbaum A. Cortical gray matter deficit in patients with bipolar disorder. Schizophr Res 1999; 40: 219-227.
Pearlson GD, Barta PE, Powers RE et al. Ziskind- Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry 1997; 41: 1-14.
Miguel-Hidalgo JJ, Baucom C, Dilley G et al. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 2000; 48: 861-873.
Manji HK, Lenox RH. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 1999; 46: 1328-1351.
Kato T, Shioiri T, Murashita J et al. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 1995; 25: 557-566.
Friedman WJ, Olson L, Persson H. Cells that express brain-derived neurotrophic factor mRNA in the developing postnatal brain. Eur J Neurosci 1991; 3: 688-697.
Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994; 60: 436-444.
Hughes P, Dragunow M. trkC may be an inducible transcription factor target gene. Neuroreport 1995; 6: 465-468.
Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 1999; 877: 614-637.
Manji HK, Moore GJ, Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 1999; 46: 929-940.
Jope RS. Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 1999; 4: 117-128.
Duman R, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999; 46: 1181-1191.
Figiel GS, Krishnan KR, Rao VP et al. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci 1991; 3: 18-22.
Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression [published erratum appears in Neuroreport 1998; 9: 2436]. Neuroreport 1998; 9: 2023-2028.
Whitaker-Azmitia P, Clarke C, Azmitia E. Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action. Synapse 1993; 14: 201-205.
Lopez JF, Little KY, Watson SJ. Corticosteroid receptor regulation in the brain of suicide victims. Biol Psychiatry 2000; 47: 87S87S.
Healy DG, Harkin A, Cryan JF, Kelly JP, Leonard BE. Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology (Berl) 1999; 145: 303-308.
Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998; 55: 215-224.
Baumann B, Danos P, Krell D et al. Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology. J Affect Disord 1999; 54: 217-224.
Buchsbaum MS, Wu J, DeLisi LE et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 1986; 10: 137-152.
Pandey GN, Dwivedi Y, Pandey SC et al. Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects. Am J Psychiatry 1999; 156: 1895-1901.
Altshuler LL, Conrad A, Hauser P et al. Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging [letter]. Arch Gen Psychiatry 1991; 48: 482-483.
Deicken RF, Fein G, Weiner MW. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am J Psychiatry 1995; 152: 915-918.
Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58: 545-553.
Griffith R, Sutin J. Reactive astrocyte formation in vivo is regulated by noradrenergic axons. J Comp Neurol 1996; 371: 362-375.DOI: 10.1002/(sici)1096-9861(19960729)371:3<362::aid-cne2>3.0.co;2-0
Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT. G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 1999; 73: 1121-1126.DOI: 10.1046/j.1471-4159.1999.0731121.x
Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000; 48: 755-765.
Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000; 47: 475-481.
Johnston-Wilson NL, Sims CD, Hofmann JP et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathol Consortium. Mol Psychiatry 2000; 5: 142-149.
Holsboer F, Spengler D, Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 1992; 93: 385-417.
Maisonpierre PC, Belluscio L, Friedman B et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 1990; 5: 501-509.
Rajkowska G, Miguel-Hidalgo JJ, Wei J et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085-1098.
Steffens D, Krishnan K. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43: 705-712.
Manji HK, Moore GJ, Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 2000; 61: 82-96.
Deicken RF, Weiner MW, Fein G. Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 1995; 33: 195-199.
Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990; 10: 2897-2902.
Ohgoh M, Kimura M, Ogura H, Katayama K, Nishizawa Y. Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial trophic support. Exp Neurol 1998; 149: 51-63.
Coffman JA, Bornstein RA, Olson SC, Schwarzkopf SB, Nasrallah HA. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1990; 27: 1188-1196.
Hollister LE, Claghorn JL. New antidepressants. Annu Rev Pharmacol Toxicol 1993; 33: 165-177.
Raadsheer FC, Van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995; 152: 1372-1376.
Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 2000; 75: 1729-1734.
Gould E, Tanapat P. Stress and hippocampal neurogenesis. Biol Psychiatry 1999; 46: 1472-1479.
Blumberg HP, Stern E, Ricketts S et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry 1999; 156: 1986-1988.
Mennerick S, Zorumski CF. Glial contributions to excitatory neurotransmission in cultured hippocampal cells. Nature 1994; 368: 59-62.
Sapolsky RM, Stein-Behrens BA, Armanini MP. Long-term adrenalectomy causes loss of dentate gyrus and pyramidal neurons in the adult hippocampus. Exp Neurol 1991; 114: 246-249.
Chen G, Zeng
2001; 50
1990; 10
1991; 114
2000; 47
2000; 48
2000; 5
1997; 41
1997; 154
1995; 34
1995; 33
2000; 41
1997; 277
1999; 46
1999; 45
2001; 49
1999; 40
1989; 46
1998; 43
1994; 60
1992; 93
1998; 44
1998; 395
1985; 69
1995; 61
1982; 28
1991; 48
1990; 47
1997; 54
2000; 126
1995; 25
1993; 33
1994; 263
1997; 386
1982; 4
1996; 371
2000; 61
1999; 54
1994; 35
1999; 10
1998; 95
2001; 58
1992; 2
1998; 55
2001; 98
1995; 52
1991; 3
1989; 1
1991; 133
1985; 5
1997; 22
2000; 26
1986; 10
1995; 15
1994; 151
1999; 4
2000; 275
1999; 145
1999; 60
1999; 821
1996; 169
1996; 16
1995; 152
1993; 187
1995; 6
1996; 53
1993; 14
1992; 70
1994; 368
1990; 27
1999; 39
1995; 46
1993; 54
1999; 36
2000; 75
1999; 274
1996; 153
1999; 73
1999; 156
1999; 354
1999; 72
1998; 149
1999; 877
1996; 279
1998; 78
1998; 9
1990; 5
1994; 6
George MS (e_1_2_8_22_2) 1993; 54
e_1_2_8_49_2
e_1_2_8_45_2
e_1_2_8_26_2
e_1_2_8_68_2
e_1_2_8_9_2
Pandey GN (e_1_2_8_70_2) 1999; 156
Orlovskaya DD (e_1_2_8_41_2) 1999; 36
e_1_2_8_5_2
Bowley MP (e_1_2_8_36_2) 2000; 26
e_1_2_8_87_2
e_1_2_8_64_2
e_1_2_8_83_2
e_1_2_8_60_2
e_1_2_8_38_2
e_1_2_8_19_2
e_1_2_8_109_2
e_1_2_8_34_2
e_1_2_8_15_2
e_1_2_8_57_2
e_1_2_8_91_2
e_1_2_8_95_2
Shimizu M (e_1_2_8_51_2) 1996; 279
e_1_2_8_99_2
e_1_2_8_30_2
e_1_2_8_76_2
e_1_2_8_105_2
e_1_2_8_11_2
e_1_2_8_53_2
e_1_2_8_72_2
e_1_2_8_101_2
e_1_2_8_25_2
e_1_2_8_48_2
e_1_2_8_67_2
Manji HK (e_1_2_8_89_2) 2000; 61
e_1_2_8_2_2
e_1_2_8_6_2
e_1_2_8_21_2
e_1_2_8_44_2
e_1_2_8_63_2
e_1_2_8_86_2
e_1_2_8_40_2
e_1_2_8_18_2
e_1_2_8_14_2
e_1_2_8_37_2
e_1_2_8_56_2
e_1_2_8_79_2
e_1_2_8_90_2
e_1_2_8_94_2
e_1_2_8_98_2
e_1_2_8_10_2
e_1_2_8_33_2
e_1_2_8_52_2
e_1_2_8_75_2
e_1_2_8_106_2
e_1_2_8_71_2
e_1_2_8_102_2
e_1_2_8_28_2
e_1_2_8_24_2
e_1_2_8_47_2
e_1_2_8_3_2
e_1_2_8_7_2
e_1_2_8_20_2
e_1_2_8_66_2
e_1_2_8_43_2
e_1_2_8_85_2
e_1_2_8_62_2
e_1_2_8_81_2
Blumberg HP (e_1_2_8_4_2) 1999; 156
e_1_2_8_17_2
e_1_2_8_13_2
e_1_2_8_59_2
e_1_2_8_78_2
e_1_2_8_97_2
e_1_2_8_55_2
Bertolino A (e_1_2_8_29_2) 1999; 45
e_1_2_8_32_2
e_1_2_8_74_2
e_1_2_8_107_2
e_1_2_8_93_2
e_1_2_8_103_2
e_1_2_8_27_2
e_1_2_8_23_2
e_1_2_8_46_2
e_1_2_8_69_2
e_1_2_8_80_2
Manji HK (e_1_2_8_82_2) 1999; 60
e_1_2_8_8_2
e_1_2_8_42_2
e_1_2_8_65_2
e_1_2_8_88_2
e_1_2_8_61_2
e_1_2_8_84_2
e_1_2_8_16_2
e_1_2_8_39_2
e_1_2_8_12_2
e_1_2_8_35_2
e_1_2_8_58_2
e_1_2_8_108_2
e_1_2_8_96_2
e_1_2_8_31_2
e_1_2_8_54_2
e_1_2_8_77_2
e_1_2_8_104_2
e_1_2_8_50_2
e_1_2_8_73_2
e_1_2_8_100_2
e_1_2_8_92_2
15005758 - Bipolar Disord. 2004 Apr;6(2):168-9
References_xml – reference: Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58: 545-553.
– reference: Lim KO, Rosenbloom MJ, Faustman WO, Sullivan EV, Pfefferbaum A. Cortical gray matter deficit in patients with bipolar disorder. Schizophr Res 1999; 40: 219-227.
– reference: Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000; 47: 475-481.
– reference: Raadsheer FC, Van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995; 152: 1372-1376.
– reference: Herman JP, Adams D, Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995; 61: 180-190.
– reference: Manji HK, Moore GJ, Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 2000; 61: 82-96.
– reference: Healy DG, Harkin A, Cryan JF, Kelly JP, Leonard BE. Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology (Berl) 1999; 145: 303-308.
– reference: Deicken RF, Weiner MW, Fein G. Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 1995; 33: 195-199.
– reference: Hoogendijk JE, Fliers E, Swaab DF, Verwer RW. Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia. J Neurol Sci 1985; 69: 291-299.
– reference: Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295.
– reference: Watanabe Y, Gould E, Cameron HA, Daniels DC, McEwen BS. Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 1992; 2: 431-435.
– reference: Baumann B, Danos P, Krell D et al. Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology. J Affect Disord 1999; 54: 217-224.
– reference: Botteron KN, Vannier MW, Geller B, Todd RD, Lee BC. Preliminary study of magnetic resonance imaging characteristics in 8- to 16-year-olds with mania. J Am Acad Child Adolesc Psychiatry 1995; 34: 742-749.
– reference: Altshuler LL, Bartzokis G, Grieder T, Curran J, Mintz J. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry 1998; 55: 663-664.
– reference: Pfrieger FW, Barres BA. Synaptic efficacy enhanced by glial cells in vitro. Science 1997; 277: 1684-1687.
– reference: Lopez JF, Little KY, Watson SJ. Corticosteroid receptor regulation in the brain of suicide victims. Biol Psychiatry 2000; 47: 87S87S.
– reference: Steffens D, Krishnan K. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43: 705-712.
– reference: Pearlson GD. Structural and functional brain changes in bipolar disorder: a selective review. Schizophr Res 1999; 39: 133-140; Discussion 162.
– reference: Nasrallah HA, McCalley-Whitters M, Jacoby CG. Cerebral ventricular enlargement in young manic males. A controlled CT study. J Affect Disord 1982; 4: 15-19.
– reference: Hollister LE, Claghorn JL. New antidepressants. Annu Rev Pharmacol Toxicol 1993; 33: 165-177.
– reference: Johnston-Wilson NL, Sims CD, Hofmann JP et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathol Consortium. Mol Psychiatry 2000; 5: 142-149.
– reference: Rajkowska G. Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits? Prog Brain Res 2000; 126: 397-412.
– reference: Hedreen JC, Peyser CE, Folstein SE, Ross CA. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 1991; 133: 257-261.
– reference: Hauser P, Altshuler LL, Berrettini W, Dauphinais ID, Gelernter J, Post RM. Temporal lobe measurement in primary affective disorder by magnetic resonance imaging. J Neuropsychiatry Clin Neurosci 1989; 1: 128-134.
– reference: Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994; 60: 436-444.
– reference: Frolkis VV, Golovchenko SF, Medved VI, Frolkis RA. Vasopressin and cardiovascular system in aging. Gerontology 1982; 28: 290-302.
– reference: Maisonpierre PC, Belluscio L, Friedman B et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 1990; 5: 501-509.
– reference: Kato T, Shioiri T, Murashita J et al. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 1995; 25: 557-566.
– reference: Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression [published erratum appears in Neuroreport 1998; 9: 2436]. Neuroreport 1998; 9: 2023-2028.
– reference: Rajkowska G, Miguel-Hidalgo JJ, Wei J et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085-1098.
– reference: Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 1999; 877: 614-637.
– reference: Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1155-1163.
– reference: Khan ZU, Koulen P, Rubinstein M, Grandy DK, Goldman-Rakic PS. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc Natl Acad Sci USA 2001; 98: 1964-1969.
– reference: Orlovskaya DD, Vostrikov VM, Rachmanova NA, Uranova NA. Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia, bipolar affective disorder and major depression. Schizophr Res 2000; 41: 105105.
– reference: Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 1996; 53: 137-143.
– reference: Drevets W, Price J, Simpson J. et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-827.
– reference: Pandey GN, Dwivedi Y, Pandey SC et al. Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects. Am J Psychiatry 1999; 156: 1895-1901.
– reference: Lucassen PJ, Salehi A, Pool CW, Gonatas NK, Swaab DF. Activation of vasopressin neurons in aging and Alzheimer's disease. J Neuroendocrinol 1994; 6: 673-679.
– reference: Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998; 55: 215-224.
– reference: Orlovskaya DD, Vikhreva OV, Zimina IS, Denisov DV, Uranova NA. Ultrastructural dystrophic changes of oligodendroglial cells in autopsied prefrontal cortex and striatum in schizophrenia: a morphometric study. Schizophr Res 1999; 36: 82-83.
– reference: Lopez JF, Akil H, Watson SJ. Neural circuits mediating stress. Biol Psychiatry 1999; 46: 1461-1471.
– reference: Mennerick S, Zorumski CF. Glial contributions to excitatory neurotransmission in cultured hippocampal cells. Nature 1994; 368: 59-62.
– reference: Bowley MP, Drevets WC, Ongur D, Price JL. Glial changes in the amygdala and entorhinal cortex in mood disorders. Soc Neurosci Abstr 2000; 26: 23132313.
– reference: Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539-7547.
– reference: Buchsbaum MS, Wu J, DeLisi LE et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 1986; 10: 137-152.
– reference: Verkhratsky A, Orkand RK, Kettenmann H. Glial calcium: homeostasis and signaling function. Physiol Rev 1998; 78: 99-141.
– reference: Ohgoh M, Kimura M, Ogura H, Katayama K, Nishizawa Y. Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial trophic support. Exp Neurol 1998; 149: 51-63.
– reference: Dupont RM, Jernigan TL, Heindel W et al. Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 1995; 52: 747-755.
– reference: Miguel-Hidalgo JJ, Baucom C, Dilley G et al. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 2000; 48: 861-873.
– reference: Benes FM, Vincent SL, Todtenkopf MS. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 2001; 50: 395-406.
– reference: Lu R, Song L, Jope RS. Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. Neuroreport 1999; 10: 1123-1125.
– reference: Blumberg HP, Stern E, Ricketts S et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry 1999; 156: 1986-1988.
– reference: Manji HK, Moore GJ, Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 1999; 46: 929-940.
– reference: Bertolino A, Frye M, Callicott JH et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder. Biol Psychiatry 1999; 45: 135S135S.
– reference: Altshuler LL, Conrad A, Hauser P et al. Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging [letter]. Arch Gen Psychiatry 1991; 48: 482-483.
– reference: Coffman JA, Bornstein RA, Olson SC, Schwarzkopf SB, Nasrallah HA. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1990; 27: 1188-1196.
– reference: Tsai G, Coyle JT. N-Acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995; 46: 531-540.
– reference: Pearlson GD, Barta PE, Powers RE et al. Ziskind- Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry 1997; 41: 1-14.
– reference: Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT. G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 1999; 73: 1121-1126.DOI: 10.1046/j.1471-4159.1999.0731121.x
– reference: Aylward EH, Roberts-Twillie JV, Barta PE et al. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 1994; 151: 687-693.
– reference: Figiel GS, Krishnan KR, Rao VP et al. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci 1991; 3: 18-22.
– reference: Al-Mousawi AH, Evans N, Ebmeier KP, Roeda D, Chaloner F, Ashcroft GW. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography. Br J Psychiatry 1996; 169: 509-516.
– reference: Moore GJ, Bebchuk JM, Hasanat K et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000; 48: 1-8.
– reference: Milner TA, Lee A, Aicher SA, Rosin DL. Hippocampal alpha2a-adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes. J Comp Neurol 1998; 395: 310-327.DOI: 10.1002/(sici)1096-9861(19980808)395:3<310::aid-cne4>3.0.co;2-5
– reference: Manji HK, Lenox RH. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 1999; 46: 1328-1351.
– reference: Soares J, Mann J. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997; 41: 86-106.
– reference: Bijur GN, De Sarno P, Jope RS. Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem 2000; 275: 7583-7590.
– reference: Huntley GW, Benson DL, Jones EG, Isackson PJ. Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex. Brain Res Dev Brain Res 1992; 70: 53-63.
– reference: Deicken RF, Fein G, Weiner MW. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am J Psychiatry 1995; 152: 915-918.
– reference: Sapolsky RM, Stein-Behrens BA, Armanini MP. Long-term adrenalectomy causes loss of dentate gyrus and pyramidal neurons in the adult hippocampus. Exp Neurol 1991; 114: 246-249.
– reference: Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999; 274: 6039-6042.
– reference: Selemon LD, Goldman-Rakic PS. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 1985; 5: 776-794.
– reference: Chen G, Zeng WZ, Yuan PX et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999; 72: 879-882.
– reference: Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990; 10: 2897-2902.
– reference: Baxter LR, Schwartz JM, Phelps ME et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46: 243-250.
– reference: Chen B, Dowlatshahi D, MacQueen G, Wang J-F, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260-265.
– reference: Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 2000; 75: 1729-1734.
– reference: Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 1998; 44: 88-97.
– reference: Shankaranarayana Rao BS, Lakshmana MK, Meti BL, Raju TR. Chronic (-) deprenyl administration alters dendritic morphology of layer III pyramidal neurons in the prefrontal cortex of adult Bonnett monkeys. Brain Res 1999; 821: 218-223.
– reference: Griffith R, Sutin J. Reactive astrocyte formation in vivo is regulated by noradrenergic axons. J Comp Neurol 1996; 371: 362-375.DOI: 10.1002/(sici)1096-9861(19960729)371:3<362::aid-cne2>3.0.co;2-0
– reference: Duman R, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999; 46: 1181-1191.
– reference: Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 1994; 35: 121-127.
– reference: Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995; 52: 805-818.
– reference: Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001; 49: 741-752.
– reference: Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 1997; 154: 1148-1150.
– reference: Elkis H, Friedman L, Wise A, Meltzer HY. Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Arch Gen Psychiatry 1995; 52: 735-746.
– reference: Hughes P, Dragunow M. trkC may be an inducible transcription factor target gene. Neuroreport 1995; 6: 465-468.
– reference: Swaab DF, Hofman MA, Lucassen PJ, Purba JS, Raadsheer FC, Van de Nes JA. Functional neuroanatomy and neuropathology of the human hypothalamus. Anat Embryol (Berl) 1993; 187: 317-330.
– reference: Hyman SE, Nestler EJ. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996; 153: 151-162.
– reference: Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 1994; 263: 1618-1623.
– reference: Gould E, Tanapat P. Stress and hippocampal neurogenesis. Biol Psychiatry 1999; 46: 1472-1479.
– reference: Shimizu M, Nishida A, Zensho H, Yamawaki S. Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes. J Pharmacol Exp Ther 1996; 279: 1551-1558.
– reference: Manji HK, Moore GJ, Rajkowska G, Chen G. Neuroplasticity and cellular resilience in mood disorders. Millenium Article. Mol Psychiatry 2000; 5: 578-593.
– reference: Swayze VWd, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WT. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. Arch Gen Psychiatry 1990; 47: 1054-1059.
– reference: George MS, Ketter TA, Post RM. SPECT and PET imaging in mood disorders. J Clin Psychiatry 1993; 54 (Suppl.): 6-13.
– reference: Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000; 48: 755-765.
– reference: Holsboer F, Spengler D, Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 1992; 93: 385-417.
– reference: Blumberg HP, Stern E, Martinez D et al. Increased anterior cingulate and caudate activity in bipolar mania [In Process Citation]. Biol Psychiatry 2000; 48: 1045-1052.
– reference: Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
– reference: Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 1999; 60: 27-39; Discussion 40-21: 113-116.
– reference: Friedman WJ, Olson L, Persson H. Cells that express brain-derived neurotrophic factor mRNA in the developing postnatal brain. Eur J Neurosci 1991; 3: 688-697.
– reference: Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996; 16: 877-885.
– reference: Jope RS. Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 1999; 4: 117-128.
– reference: Whitaker-Azmitia P, Clarke C, Azmitia E. Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action. Synapse 1993; 14: 201-205.
– reference: Murphy BE. Antiglucocorticoid therapies in major depression: a review. Psychoneuroendocrinology 1997; 22: S125-S132.
– volume: 151
  start-page: 687
  year: 1994
  end-page: 693
  article-title: Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder
  publication-title: Am J Psychiatry
– volume: 48
  start-page: 482
  year: 1991
  end-page: 483
  article-title: Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging [letter]
  publication-title: Arch Gen Psychiatry
– volume: 169
  start-page: 509
  year: 1996
  end-page: 516
  article-title: Limbic dysfunction in schizophrenia and mania. A study using 18F‐labelled fluorodeoxyglucose and positron emission tomography
  publication-title: Br J Psychiatry
– volume: 3
  start-page: 688
  year: 1991
  end-page: 697
  article-title: Cells that express brain‐derived neurotrophic factor mRNA in the developing postnatal brain
  publication-title: Eur J Neurosci
– volume: 15
  start-page: 7539
  year: 1995
  end-page: 7547
  article-title: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
  publication-title: J Neurosci
– volume: 33
  start-page: 165
  year: 1993
  end-page: 177
  article-title: New antidepressants
  publication-title: Annu Rev Pharmacol Toxicol
– volume: 60
  start-page: 27
  year: 1999
  end-page: 39
  article-title: Modulation of CNS signal transduction pathways and gene expression by mood‐stabilizing agents: therapeutic implications
  publication-title: J Clin Psychiatry
– volume: 5
  start-page: 501
  year: 1990
  end-page: 509
  article-title: NT‐3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression
  publication-title: Neuron
– volume: 263
  start-page: 1618
  year: 1994
  end-page: 1623
  article-title: Requirement for BDNF in activity‐dependent survival of cortical neurons
  publication-title: Science
– volume: 34
  start-page: 742
  year: 1995
  end-page: 749
  article-title: Preliminary study of magnetic resonance imaging characteristics in 8‐ to 16‐year‐olds with mania
  publication-title: J Am Acad Child Adolesc Psychiatry
– volume: 61
  start-page: 180
  year: 1995
  end-page: 190
  article-title: Regulatory changes in neuroendocrine stress‐integrative circuitry produced by a variable stress paradigm
  publication-title: Neuroendocrinology
– volume: 48
  start-page: 1
  year: 2000
  end-page: 8
  article-title: Lithium increases N‐acetyl‐aspartate in the human brain: in vivo evidence in support of bcl‐2's neurotrophic effects?
  publication-title: Biol Psychiatry
– volume: 93
  start-page: 385
  year: 1992
  end-page: 417
  article-title: The role of corticotropin‐releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia
  publication-title: Prog Brain Res
– volume: 10
  start-page: 2897
  year: 1990
  end-page: 2902
  article-title: Hippocampal damage associated with prolonged glucocorticoid exposure in primates
  publication-title: J Neurosci
– volume: 73
  start-page: 1121
  year: 1999
  end-page: 1126
  article-title: G Protein‐coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death
  publication-title: J Neurochem
– volume: 114
  start-page: 246
  year: 1991
  end-page: 249
  article-title: Long‐term adrenalectomy causes loss of dentate gyrus and pyramidal neurons in the adult hippocampus
  publication-title: Exp Neurol
– volume: 46
  start-page: 1328
  year: 1999
  end-page: 1351
  article-title: Ziskind–Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic‐depressive illness
  publication-title: Biol Psychiatry
– volume: 395
  start-page: 310
  year: 1998
  end-page: 327
  article-title: Hippocampal alpha2a‐adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes
  publication-title: J Comp Neurol
– volume: 58
  start-page: 545
  year: 2001
  end-page: 553
  article-title: Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder
  publication-title: Arch Gen Psychiatry
– volume: 46
  start-page: 929
  year: 1999
  end-page: 940
  article-title: Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
  publication-title: Biol Psychiatry
– volume: 46
  start-page: 1472
  year: 1999
  end-page: 1479
  article-title: Stress and hippocampal neurogenesis
  publication-title: Biol Psychiatry
– volume: 55
  start-page: 215
  year: 1998
  end-page: 224
  article-title: Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease
  publication-title: Arch Gen Psychiatry
– volume: 46
  start-page: 531
  year: 1995
  end-page: 540
  article-title: N‐Acetylaspartate in neuropsychiatric disorders
  publication-title: Prog Neurobiol
– volume: 1
  start-page: 128
  year: 1989
  end-page: 134
  article-title: Temporal lobe measurement in primary affective disorder by magnetic resonance imaging
  publication-title: J Neuropsychiatry Clin Neurosci
– volume: 48
  start-page: 861
  year: 2000
  end-page: 873
  article-title: Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder
  publication-title: Biol Psychiatry
– volume: 877
  start-page: 614
  year: 1999
  end-page: 637
  article-title: Prefrontal cortical‐amygdalar metabolism in major depression
  publication-title: Ann N Y Acad Sci
– volume: 152
  start-page: 915
  year: 1995
  end-page: 918
  article-title: Abnormal frontal lobe phosphorous metabolism in bipolar disorder
  publication-title: Am J Psychiatry
– volume: 153
  start-page: 151
  year: 1996
  end-page: 162
  article-title: Initiation and adaptation: a paradigm for understanding psychotropic drug action
  publication-title: Am J Psychiatry
– volume: 50
  start-page: 260
  year: 2001
  end-page: 265
  article-title: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication
  publication-title: Biol Psychiatry
– volume: 45
  start-page: 135S
  year: 1999
  end-page: 135S
  article-title: Neuronal pathology in the hippocampal area of patients with bipolar disorder
  publication-title: Biol Psychiatry
– volume: 152
  start-page: 1372
  year: 1995
  end-page: 1376
  article-title: Corticotropin‐releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression
  publication-title: Am J Psychiatry
– volume: 6
  start-page: 465
  year: 1995
  end-page: 468
  article-title: trkC may be an inducible transcription factor target gene
  publication-title: Neuroreport
– volume: 28
  start-page: 290
  year: 1982
  end-page: 302
  article-title: Vasopressin and cardiovascular system in aging
  publication-title: Gerontology
– volume: 47
  start-page: 475
  year: 2000
  end-page: 481
  article-title: Decreased dorsolateral prefrontal N‐acetyl aspartate in bipolar disorder
  publication-title: Biol Psychiatry
– volume: 277
  start-page: 1684
  year: 1997
  end-page: 1687
  article-title: Synaptic efficacy enhanced by glial cells in vitro
  publication-title: Science
– volume: 133
  start-page: 257
  year: 1991
  end-page: 261
  article-title: Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease
  publication-title: Neurosci Lett
– volume: 54
  start-page: 217
  year: 1999
  end-page: 224
  article-title: Unipolar–bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology
  publication-title: J Affect Disord
– volume: 95
  start-page: 13290
  year: 1998
  end-page: 13295
  article-title: Glial reduction in the subgenual prefrontal cortex in mood disorders
  publication-title: Proc Natl Acad Sci USA
– volume: 49
  start-page: 741
  year: 2001
  end-page: 752
  article-title: Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder
  publication-title: Biol Psychiatry
– volume: 3
  start-page: 18
  year: 1991
  end-page: 22
  article-title: Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects
  publication-title: J Neuropsychiatry Clin Neurosci
– volume: 27
  start-page: 1188
  year: 1990
  end-page: 1196
  article-title: Cognitive impairment and cerebral structure by MRI in bipolar disorder
  publication-title: Biol Psychiatry
– volume: 25
  start-page: 557
  year: 1995
  end-page: 566
  article-title: Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase‐encoded 31P‐MRS
  publication-title: Psychol Med
– volume: 126
  start-page: 397
  year: 2000
  end-page: 412
  article-title: Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?
  publication-title: Prog Brain Res
– volume: 36
  start-page: 82
  year: 1999
  end-page: 83
  article-title: Ultrastructural dystrophic changes of oligodendroglial cells in autopsied prefrontal cortex and striatum in schizophrenia: a morphometric study
  publication-title: Schizophr Res
– volume: 275
  start-page: 7583
  year: 2000
  end-page: 7590
  article-title: Glycogen synthase kinase‐3beta facilitates staurosporine‐ and heat shock‐induced apoptosis. Protection by lithium
  publication-title: J Biol Chem
– volume: 98
  start-page: 1964
  year: 2001
  end-page: 1969
  article-title: An astroglia‐linked dopamine D2‐receptor action in prefrontal cortex
  publication-title: Proc Natl Acad Sci USA
– volume: 55
  start-page: 663
  year: 1998
  end-page: 664
  article-title: Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity
  publication-title: Arch Gen Psychiatry
– volume: 43
  start-page: 705
  year: 1998
  end-page: 712
  article-title: Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions
  publication-title: Biol Psychiatry
– volume: 156
  start-page: 1895
  year: 1999
  end-page: 1901
  article-title: Low phosphoinositide‐specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects
  publication-title: Am J Psychiatry
– volume: 75
  start-page: 1729
  year: 2000
  end-page: 1734
  article-title: Enhancement of hippocampal neurogenesis by lithium
  publication-title: J Neurochem
– volume: 40
  start-page: 219
  year: 1999
  end-page: 227
  article-title: Cortical gray matter deficit in patients with bipolar disorder
  publication-title: Schizophr Res
– volume: 50
  start-page: 395
  year: 2001
  end-page: 406
  article-title: The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects
  publication-title: Biol Psychiatry
– volume: 368
  start-page: 59
  year: 1994
  end-page: 62
  article-title: Glial contributions to excitatory neurotransmission in cultured hippocampal cells
  publication-title: Nature
– volume: 45
  start-page: 1085
  year: 1999
  end-page: 1098
  article-title: Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
  publication-title: Biol Psychiatry
– volume: 4
  start-page: 117
  year: 1999
  end-page: 128
  article-title: Anti‐bipolar therapy: mechanism of action of lithium
  publication-title: Mol Psychiatry
– volume: 54
  start-page: 6
  year: 1993
  end-page: 13
  article-title: SPECT and PET imaging in mood disorders
  publication-title: J Clin Psychiatry
– volume: 44
  start-page: 88
  year: 1998
  end-page: 97
  article-title: A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
  publication-title: Biol Psychiatry
– volume: 386
  start-page: 824
  year: 1997
  end-page: 827
  article-title: Subgenual prefrontal cortex abnormalities in mood disorders
  publication-title: Nature
– volume: 279
  start-page: 1551
  year: 1996
  end-page: 1558
  article-title: Chronic antidepressant exposure enhances 5‐hydroxytryptamine7 receptor‐mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes
  publication-title: J Pharmacol Exp Ther
– volume: 154
  start-page: 1148
  year: 1997
  end-page: 1150
  article-title: Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder
  publication-title: Am J Psychiatry
– volume: 61
  start-page: 82
  year: 2000
  end-page: 96
  article-title: Lithium up‐regulates the cytoprotective protein Bcl‐2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness
  publication-title: J Clin Psychiatry
– volume: 70
  start-page: 53
  year: 1992
  end-page: 63
  article-title: Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex
  publication-title: Brain Res Dev Brain Res
– volume: 33
  start-page: 195
  year: 1995
  end-page: 199
  article-title: Decreased temporal lobe phosphomonoesters in bipolar disorder
  publication-title: J Affect Disord
– volume: 46
  start-page: 1461
  year: 1999
  end-page: 1471
  article-title: Neural circuits mediating stress
  publication-title: Biol Psychiatry
– volume: 16
  start-page: 877
  year: 1996
  end-page: 885
  article-title: Metabolic coupling between glia and neurons
  publication-title: J Neurosci
– volume: 354
  start-page: 1155
  year: 1999
  end-page: 1163
  article-title: Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging
  publication-title: Philos Trans R Soc Lond B Biol Sci
– volume: 47
  start-page: 1054
  year: 1990
  end-page: 1059
  article-title: Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities
  publication-title: Arch Gen Psychiatry
– volume: 10
  start-page: 137
  year: 1986
  end-page: 152
  article-title: Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2‐deoxyglucose in affective illness
  publication-title: J Affect Disord
– volume: 48
  start-page: 755
  year: 2000
  end-page: 765
  article-title: The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death
  publication-title: Biol Psychiatry
– volume: 54
  start-page: 597
  year: 1997
  end-page: 606
  article-title: A molecular and cellular theory of depression
  publication-title: Arch Gen Psychiatry
– volume: 5
  start-page: 776
  year: 1985
  end-page: 794
  article-title: Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey
  publication-title: J Neurosci
– volume: 22
  start-page: S125
  year: 1997
  end-page: S132
  article-title: Antiglucocorticoid therapies in major depression: a review
  publication-title: Psychoneuroendocrinology
– volume: 5
  start-page: 578
  year: 2000
  end-page: 593
  article-title: Neuroplasticity and cellular resilience in mood disorders. Millenium Article
  publication-title: Mol Psychiatry
– volume: 156
  start-page: 1986
  year: 1999
  end-page: 1988
  article-title: Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder
  publication-title: Am J Psychiatry
– volume: 187
  start-page: 317
  year: 1993
  end-page: 330
  article-title: Functional neuroanatomy and neuropathology of the human hypothalamus
  publication-title: Anat Embryol (Berl)
– volume: 78
  start-page: 99
  year: 1998
  end-page: 141
  article-title: Glial calcium: homeostasis and signaling function
  publication-title: Physiol Rev
– volume: 274
  start-page: 6039
  year: 1999
  end-page: 6042
  article-title: Long term lithium treatment suppresses p53 and Bax expression but increases Bcl‐2 expression. A prominent role in neuroprotection against excitotoxicity
  publication-title: J Biol Chem
– volume: 4
  start-page: 15
  year: 1982
  end-page: 19
  article-title: Cerebral ventricular enlargement in young manic males. A controlled CT study
  publication-title: J Affect Disord
– volume: 52
  start-page: 735
  year: 1995
  end-page: 746
  article-title: Meta‐analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders
  publication-title: Arch Gen Psychiatry
– volume: 41
  start-page: 86
  year: 1997
  end-page: 106
  article-title: The anatomy of mood disorders – review of structural neuroimaging studies
  publication-title: Biol Psychiatry
– volume: 41
  start-page: 105
  year: 2000
  end-page: 105
  article-title: Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia, bipolar affective disorder and major depression
  publication-title: Schizophr Res
– volume: 14
  start-page: 201
  year: 1993
  end-page: 205
  article-title: Localization of 5‐HT1A receptors to astroglial cells in adult rats: implications for neuronal–glial interactions and psychoactive drug mechanism of action
  publication-title: Synapse
– volume: 46
  start-page: 243
  year: 1989
  end-page: 250
  article-title: Reduction of prefrontal cortex glucose metabolism common to three types of depression
  publication-title: Arch Gen Psychiatry
– volume: 6
  start-page: 673
  year: 1994
  end-page: 679
  article-title: Activation of vasopressin neurons in aging and Alzheimer's disease
  publication-title: J Neuroendocrinol
– volume: 149
  start-page: 51
  year: 1998
  end-page: 63
  article-title: Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial trophic support
  publication-title: Exp Neurol
– volume: 47
  start-page: 87S
  year: 2000
  end-page: 87S
  article-title: Corticosteroid receptor regulation in the brain of suicide victims
  publication-title: Biol Psychiatry
– volume: 821
  start-page: 218
  year: 1999
  end-page: 223
  article-title: Chronic (–) deprenyl administration alters dendritic morphology of layer III pyramidal neurons in the prefrontal cortex of adult Bonnett monkeys
  publication-title: Brain Res
– volume: 60
  start-page: 436
  year: 1994
  end-page: 444
  article-title: Increased numbers of corticotropin‐releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
  publication-title: Neuroendocrinology
– volume: 69
  start-page: 291
  year: 1985
  end-page: 299
  article-title: Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia
  publication-title: J Neurol Sci
– volume: 52
  start-page: 805
  year: 1995
  end-page: 818
  article-title: Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17
  publication-title: Arch Gen Psychiatry
– volume: 2
  start-page: 431
  year: 1992
  end-page: 435
  article-title: Phenytoin prevents stress‐ and corticosterone‐induced atrophy of CA3 pyramidal neurons
  publication-title: Hippocampus
– volume: 72
  start-page: 879
  year: 1999
  end-page: 882
  article-title: The mood‐stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl‐2 in the CNS
  publication-title: J Neurochem
– volume: 52
  start-page: 747
  year: 1995
  end-page: 755
  article-title: Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities
  publication-title: Arch Gen Psychiatry
– volume: 5
  start-page: 142
  year: 2000
  end-page: 149
  article-title: Disease‐specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathol Consortium
  publication-title: Mol Psychiatry
– volume: 145
  start-page: 303
  year: 1999
  end-page: 308
  article-title: Metyrapone displays antidepressant‐like properties in preclinical paradigms
  publication-title: Psychopharmacology (Berl)
– volume: 10
  start-page: 1123
  year: 1999
  end-page: 1125
  article-title: Lithium attenuates p53 levels in human neuroblastoma SH‐SY5Y cells
  publication-title: Neuroreport
– volume: 46
  start-page: 1181
  year: 1999
  end-page: 1191
  article-title: Neural plasticity to stress and antidepressant treatment
  publication-title: Biol Psychiatry
– volume: 9
  start-page: 2023
  year: 1998
  end-page: 2028
  article-title: Amygdala core nuclei volumes are decreased in recurrent major depression [published erratum appears in Neuroreport 1998; 9: 2436]
  publication-title: Neuroreport
– volume: 371
  start-page: 362
  year: 1996
  end-page: 375
  article-title: Reactive astrocyte formation in vivo is regulated by noradrenergic axons
  publication-title: J Comp Neurol
– volume: 41
  start-page: 1
  year: 1997
  end-page: 14
  article-title: Ziskind– Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder
  publication-title: Biol Psychiatry
– volume: 48
  start-page: 1045
  year: 2000
  end-page: 1052
  article-title: Increased anterior cingulate and caudate activity in bipolar mania [In Process Citation]
  publication-title: Biol Psychiatry
– volume: 53
  start-page: 137
  year: 1996
  end-page: 143
  article-title: Increased number of vasopressin‐ and oxytocin‐expressing neurons in the paraventricular nucleus of the hypothalamus in depression
  publication-title: Arch Gen Psychiatry
– volume: 39
  start-page: 133
  year: 1999
  end-page: 140
  article-title: Structural and functional brain changes in bipolar disorder: a selective review
  publication-title: Schizophr Res
– volume: 35
  start-page: 121
  year: 1994
  end-page: 127
  article-title: Reduced brain 5‐HT and elevated NE turnover and metabolites in bipolar affective disorder
  publication-title: Biol Psychiatry
– volume: 26
  start-page: 2313
  year: 2000
  end-page: 2313
  article-title: Glial changes in the amygdala and entorhinal cortex in mood disorders
  publication-title: Soc Neurosci Abstr
– ident: e_1_2_8_63_2
  doi: 10.1016/0022-510X(85)90141-8
– ident: e_1_2_8_86_2
  doi: 10.1016/S0006-3223(99)00165-1
– ident: e_1_2_8_92_2
  doi: 10.1016/S0006-8993(98)01362-6
– ident: e_1_2_8_13_2
  doi: 10.1176/ajp.151.5.687
– ident: e_1_2_8_81_2
  doi: 10.1016/S0006-3223(99)00177-8
– ident: e_1_2_8_72_2
  doi: 10.1016/S0165-0327(98)00168-2
– ident: e_1_2_8_88_2
  doi: 10.1074/jbc.275.11.7583
– ident: e_1_2_8_66_2
  doi: 10.1176/ajp.153.2.151
– ident: e_1_2_8_24_2
  doi: 10.1016/S0006-3223(98)00084-5
– ident: e_1_2_8_28_2
  doi: 10.1192/bjp.169.4.509
– ident: e_1_2_8_75_2
  doi: 10.1016/S0079-6123(00)26026-3
– ident: e_1_2_8_101_2
  doi: 10.1523/JNEUROSCI.10-09-02897.1990
– ident: e_1_2_8_42_2
  doi: 10.1523/JNEUROSCI.16-03-00877.1996
– ident: e_1_2_8_27_2
  doi: 10.1016/0165-0327(94)00089-R
– ident: e_1_2_8_83_2
  doi: 10.1016/S0006-3223(01)01083-6
– ident: e_1_2_8_3_2
  doi: 10.1016/0165-0327(82)90014-3
– ident: e_1_2_8_49_2
  doi: 10.1002/(sici)1096-9861(19960729)371:3<362::aid-cne2>3.0.co;2-0
– ident: e_1_2_8_65_2
  doi: 10.1097/00001756-199502000-00015
– ident: e_1_2_8_67_2
  doi: 10.1016/S0006-3223(99)00235-8
– volume: 26
  start-page: 2313
  year: 2000
  ident: e_1_2_8_36_2
  article-title: Glial changes in the amygdala and entorhinal cortex in mood disorders
  publication-title: Soc Neurosci Abstr
– ident: e_1_2_8_46_2
  doi: 10.1038/368059a0
– ident: e_1_2_8_14_2
  doi: 10.1016/S0006-3223(96)00373-3
– ident: e_1_2_8_97_2
  doi: 10.1126/science.7907431
– ident: e_1_2_8_74_2
– ident: e_1_2_8_64_2
  doi: 10.1111/j.1365-2826.1994.tb00634.x
– volume: 61
  start-page: 82
  year: 2000
  ident: e_1_2_8_89_2
  article-title: Lithium up‐regulates the cytoprotective protein Bcl‐2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness
  publication-title: J Clin Psychiatry
– ident: e_1_2_8_5_2
  doi: 10.1038/386824a0
– ident: e_1_2_8_61_2
  doi: 10.1016/S0079-6123(08)64586-0
– ident: e_1_2_8_12_2
  doi: 10.1176/jnp.3.1.18
– ident: e_1_2_8_108_2
  doi: 10.1016/S0306-4530(97)00021-8
– ident: e_1_2_8_9_2
  doi: 10.1001/archpsyc.1991.01810290094018
– ident: e_1_2_8_57_2
  doi: 10.1001/archpsyc.1996.01830020055007
– ident: e_1_2_8_104_2
  doi: 10.1523/JNEUROSCI.15-11-07539.1995
– ident: e_1_2_8_54_2
  doi: 10.1016/S0006-3223(98)00138-3
– ident: e_1_2_8_53_2
  doi: 10.1073/pnas.98.4.1964
– ident: e_1_2_8_48_2
  doi: 10.1146/annurev.pa.33.040193.001121
– ident: e_1_2_8_93_2
  doi: 10.1016/0165-3806(92)90103-4
– volume: 156
  start-page: 1895
  year: 1999
  ident: e_1_2_8_70_2
  article-title: Low phosphoinositide‐specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.156.12.1895
– ident: e_1_2_8_8_2
  doi: 10.1176/jnp.1.2.128
– ident: e_1_2_8_76_2
  doi: 10.1001/archpsyc.55.3.215
– ident: e_1_2_8_78_2
  doi: 10.1001/archpsyc.1995.03950220015005
– volume: 156
  start-page: 1986
  year: 1999
  ident: e_1_2_8_4_2
  article-title: Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.156.12.1986
– ident: e_1_2_8_30_2
  doi: 10.1016/S0006-3223(99)00183-3
– ident: e_1_2_8_34_2
  doi: 10.1016/S0006-3223(01)01080-0
– ident: e_1_2_8_37_2
  doi: 10.1001/archpsyc.58.6.545
– ident: e_1_2_8_60_2
  doi: 10.1007/BF00185889
– ident: e_1_2_8_100_2
  doi: 10.1016/0014-4886(91)90041-A
– ident: e_1_2_8_45_2
  doi: 10.1152/physrev.1998.78.1.99
– ident: e_1_2_8_109_2
  doi: 10.1007/s002130051062
– ident: e_1_2_8_11_2
  doi: 10.1001/archpsyc.1995.03950210041009
– ident: e_1_2_8_52_2
  doi: 10.1002/syn.890140303
– ident: e_1_2_8_17_2
  doi: 10.1016/S0920-9964(99)00112-7
– ident: e_1_2_8_77_2
  doi: 10.1016/0304-3940(91)90583-F
– ident: e_1_2_8_84_2
  doi: 10.1046/j.1471-4159.1999.0731121.x
– ident: e_1_2_8_55_2
  doi: 10.1016/S0006-3223(01)01084-8
– ident: e_1_2_8_95_2
  doi: 10.1016/0896-6273(90)90089-X
– volume: 54
  start-page: 6
  year: 1993
  ident: e_1_2_8_22_2
  article-title: SPECT and PET imaging in mood disorders
  publication-title: J Clin Psychiatry
– volume: 60
  start-page: 27
  year: 1999
  ident: e_1_2_8_82_2
  article-title: Modulation of CNS signal transduction pathways and gene expression by mood‐stabilizing agents: therapeutic implications
  publication-title: J Clin Psychiatry
– ident: e_1_2_8_107_2
  doi: 10.1016/S0006-3223(00)00552-7
– ident: e_1_2_8_19_2
  doi: 10.1016/0165-0327(86)90036-4
– ident: e_1_2_8_31_2
  doi: 10.1016/S0006-3223(00)00252-3
– volume: 36
  start-page: 82
  year: 1999
  ident: e_1_2_8_41_2
  article-title: Ultrastructural dystrophic changes of oligodendroglial cells in autopsied prefrontal cortex and striatum in schizophrenia: a morphometric study
  publication-title: Schizophr Res
– ident: e_1_2_8_105_2
  doi: 10.1016/S0006-3223(99)00266-8
– ident: e_1_2_8_16_2
  doi: 10.1001/archpsyc.55.7.663
– ident: e_1_2_8_23_2
  doi: 10.1016/S0006-3223(00)00962-8
– ident: e_1_2_8_98_2
  doi: 10.1006/exnr.1997.6719
– ident: e_1_2_8_18_2
  doi: 10.1016/S0006-3223(96)00006-6
– ident: e_1_2_8_69_2
  doi: 10.1176/ajp.154.8.1148
– ident: e_1_2_8_21_2
  doi: 10.1001/archpsyc.1989.01810030049007
– ident: e_1_2_8_106_2
  doi: 10.1159/000126839
– ident: e_1_2_8_50_2
  doi: 10.1002/(sici)1096-9861(19980808)395:3<310::aid-cne4>3.0.co;2-5
– ident: e_1_2_8_44_2
  doi: 10.1126/science.277.5332.1684
– ident: e_1_2_8_6_2
  doi: 10.1016/S0920-9964(99)00063-8
– ident: e_1_2_8_35_2
  doi: 10.1016/S0920-9964(00)90551-6
– ident: e_1_2_8_102_2
  doi: 10.1002/hipo.450020410
– ident: e_1_2_8_96_2
– ident: e_1_2_8_26_2
  doi: 10.1176/ajp.152.6.915
– ident: e_1_2_8_94_2
  doi: 10.1111/j.1460-9568.1991.tb00854.x
– ident: e_1_2_8_68_2
  doi: 10.1038/sj.mp.4000494
– ident: e_1_2_8_47_2
– ident: e_1_2_8_43_2
  doi: 10.1098/rstb.1999.0471
– ident: e_1_2_8_80_2
  doi: 10.1001/archpsyc.1997.01830190015002
– ident: e_1_2_8_7_2
  doi: 10.1016/0006-3223(90)90416-Y
– ident: e_1_2_8_56_2
  doi: 10.1523/JNEUROSCI.05-03-00776.1985
– ident: e_1_2_8_15_2
  doi: 10.1097/00001756-199806220-00021
– ident: e_1_2_8_85_2
  doi: 10.1038/sj.mp.4000811
– ident: e_1_2_8_10_2
  doi: 10.1001/archpsyc.1990.01810230070011
– ident: e_1_2_8_73_2
  doi: 10.1016/0006-3223(94)91201-7
– ident: e_1_2_8_33_2
  doi: 10.1073/pnas.95.22.13290
– ident: e_1_2_8_103_2
  doi: 10.1196/annals.1316.075
– ident: e_1_2_8_62_2
  doi: 10.1159/000212546
– ident: e_1_2_8_32_2
  doi: 10.1016/0301-0082(95)00014-M
– ident: e_1_2_8_39_2
  doi: 10.1016/S0006-3223(00)00999-9
– ident: e_1_2_8_25_2
  doi: 10.1017/S003329170003347X
– volume: 279
  start-page: 1551
  year: 1996
  ident: e_1_2_8_51_2
  article-title: Chronic antidepressant exposure enhances 5‐hydroxytryptamine7 receptor‐mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes
  publication-title: J Pharmacol Exp Ther
– ident: e_1_2_8_87_2
  doi: 10.1046/j.1471-4159.2000.0751729.x
– ident: e_1_2_8_2_2
  doi: 10.1001/archpsyc.1995.03950210029008
– ident: e_1_2_8_90_2
  doi: 10.1097/00001756-199904060-00040
– ident: e_1_2_8_59_2
  doi: 10.1159/000126778
– ident: e_1_2_8_71_2
  doi: 10.1074/jbc.274.10.6039
– ident: e_1_2_8_38_2
  doi: 10.1016/S0006-3223(99)00041-4
– volume: 45
  start-page: 135S
  year: 1999
  ident: e_1_2_8_29_2
  article-title: Neuronal pathology in the hippocampal area of patients with bipolar disorder
  publication-title: Biol Psychiatry
– ident: e_1_2_8_79_2
  doi: 10.1097/00004583-199506000-00014
– ident: e_1_2_8_58_2
  doi: 10.1176/ajp.152.9.1372
– ident: e_1_2_8_20_2
  doi: 10.1111/j.1749-6632.1999.tb09292.x
– ident: e_1_2_8_99_2
  doi: 10.1016/S0006-3223(00)00971-9
– ident: e_1_2_8_91_2
  doi: 10.1046/j.1471-4159.1999.720879.x
– ident: e_1_2_8_40_2
  doi: 10.1038/sj.mp.4000696
– reference: 15005758 - Bipolar Disord. 2004 Apr;6(2):168-9
SSID ssj0016205
Score 2.0975099
SecondaryResourceType review_article
Snippet Objectives: The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD)...
The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD) to...
Objectives: The objective of this paper is to review findings of morphometric postmortem studies conducted on tissues from subjects with bipolar disorder (BPD)...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 105
SubjectTerms Bipolar Disorder - pathology
Brain - pathology
Cell Count
frontal cortex
glia
Humans
mood disorders
Nerve Degeneration - pathology
Neuroglia - pathology
neuropathology
postmortem
Title Cell pathology in bipolar disorder
URI https://api.istex.fr/ark:/67375/WNG-92BLFLFX-7/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1034%2Fj.1399-5618.2002.01149.x
https://www.ncbi.nlm.nih.gov/pubmed/12071508
https://www.proquest.com/docview/17584775
https://www.proquest.com/docview/71834700
Volume 4
WOSCitedRecordID wos000175195800004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1399-5618
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0016205
  issn: 1398-5647
  databaseCode: DRFUL
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS-QwEB90V8QXz6_T1VOLyL3V6zZtJ3n0qyqsi4hy-xbSJoXFpcquin--kzTuIZwg4lsfMmVmksn8kpnMAOxnBOkzY0yos7QME1RkUshUWCiGzKRM64q7ZhPY7_PBQFz5_Cf7FqapDzG9cLOW4fZra-CqmPhn4klj5ORcQ_L_3GUaHFhoLw4IT7ZjWsZJC9on1_ltbxpTyGKX0EhUnKgS9Hk9NPTPR_9656zaVu8v_0Oi74Gt80z5j--UaQkWPT4NDpsFtQwzpl6B-UsfgV-FvWMzGgW2j7G7jw-GdVAMH-z5ONC-kOca3OanN8fnoe-zEJYpIbwwrrAQXCgRc654lFY6jlAnpopKZGlmVMEKUVnoUlVKG0GYQYmiq7JIo0Kt2U9o1fe12YAAbZSTzpScC2KchImrKDG0hwmtU426A_imUFn6IuS2F8ZIumA4S-xhhFQgrQpsi8xYOhXIlw50p5QPTSGOT9D8dnM2JVDjO5vIhqn82z-TIj7q5b18ILEDu2-TKsm8bMxE1eb-aSIJXZH_xvTjEeTcWYJR1IH1ZjX8Y4_UaMvtk9Bu0j_Ntzw6uehe0-fmlym3YMH1rXE5Rr-g9Th-MtswVz4_DifjHZjFAd_xBvIK6TQH-w
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB7Kbml76fuxfcWU0psTr2V5pGOT1E2os5SQ0L0J2ZJh6eKETVLy8zsjK1sCDYTSmw8eIY00mk-a0XwAH0uC9KX3PnWlbNMCLZkUCps2VqDwUjjXqUA2gbOZms_190gHxG9hhvoQ6ws3toywX7OB84V0fCdeDFZO3jUlAKBCqsEmY3u9SYByXNCqkiMY7x5Wx_U6qFDmIaORpBRJFRgTe6i1rZvauuatxqz4y79B0evINrim6tF_HdRjeBgRavJ5WFJP4I7vn8K9gxiDfwYfdvxymTCTcbiRTxZ90ixO-YScuFjK8zkcV1-OdvbSyLSQtpIwXpp32Gilrc6VsiqTncszdIXvshaFLL1tRKM7Bi9dZ53XhBqsbqa2zBxadE68gFF_0vtXkCDHOelUqZSmjtNg8i4rPO1i2jnp0E0ArzRq2liGnNkwliaEw0XBxxFSgWEVMElmboIKzOUEpmvJ06EUxy1kPoVJWwvY1U9OZUNpfsy-Gp1v11VdzQ1OYONqVg0ZGEdNbO9PLs4M4Svy4Chv_oPcuygwyybwclgOf7pHauSC-zToMOu37rfZ3t2fHtLn63-W3ID7e0cHtan3Z9_ewIPAYhMyjt7C6Hx14d_B3fbX-eJs9T7ayW-eGgsD
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fSxwxEB7EE-lLW_tDr626lNK3tXubzU7yWD1XpddDpNJ7C9lNAofHepxa_PM7ycYrgoIU3_ZhJySTfJkvmckMwJeSKH1prU1NyZu0QE2QQqbTWjNkljNjnAjFJnA8FpOJPI3lgPxbmC4_xPLCzSMj7Nce4HZuXHwnXnQoJ-uaEgEQIdRgz3N7uUeEsldwWRJKe8Oz6ny0dCqUeYhoJClBUgXGwB5q7dtjbd2zVj2v-NuHqOh9ZhtMU_XqWQf1Gl5Ghpp875bUBqzY9g2s_4w--Lfw-cDOZomvZBxu5JNpm9TTuT8hJyam8nwH59Xhr4PjNFZaSBtOHC_NHdZSSC1zIbTIuDN5hqawLmuQ8dLqmtXSefLinDZWEmvQsh7oMjOo0Rj2Hlbby9ZuQYLez0mnSiEkdZwGk7ussLSLSWO4QdMHvNOoamIacl8NY6aCO5wV_jhCKlBeBb5IZq6CCtRtHwZLyXmXiuMJMl_DpC0F9OLCh7IhV7_HR0rm-6NqVE0U9mH3blYVAcx7TXRrL2-uFPErsuDIH_-DzDsrMMv6sNkth3_dIzX6hPs06DDrT-632h-eDM7o88N_S-7C-umwUqOT8Y-P8CIUsQkBR59g9XpxY7dhrflzPb1a7ESY_AUU2Ap-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell+pathology+in+bipolar+disorder&rft.jtitle=Bipolar+disorders&rft.au=Rajkowska%2C+Grazyna&rft.date=2002-04-01&rft.issn=1398-5647&rft.volume=4&rft.issue=2&rft.spage=105&rft_id=info:doi/10.1034%2Fj.1399-5618.2002.01149.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1398-5647&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1398-5647&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1398-5647&client=summon